Ghent University Academic Bibliography

Journal Article
A1
open access

Tumor Treating Fields therapy in platinum-resistant ovarian cancer : results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study

Ignace Vergote, Larry J. Copeland, Toon Van Gorp, Annouschka Laenen, Giovanni Scambia, Premal H. Thaker, David Cibula, Nicoletta Colombo, Jayanthi Lea, Antonio Gonzalez-Martin, et al.

(2025) EUROPEAN JOURNAL OF CANCER. 219.

Add to list

Preliminary safety and pharmacokinetics of the MET-TKI DO-2 in patients with advanced solid tumors harboring MET aberrations : a phase I study

T. Perera, B. Sikkema, B. Dekeyser, P. de Bruijn, F. Zammit, R. Galot, J. P. Machielsjean-pascal, Brant Delafontaine (UGent) , Sylvie Rottey (UGent) , A. Swalduz, et al.

(2024) EUROPEAN JOURNAL OF CANCER. In European Journal of Cancer 211(Supplement 1). p.S58-S59

Add to list

Journal Article
A1
open access

Improving completion rates of patient-reported outcome measures in cancer clinical trials : scoping review investigating the implications for trial designs

Lotte van der Weijst, Abigirl Machingura, Ahu Alanya, Emma Lidington, Galina Velikova, Hans-Henning Flechtner, Heike Schmidt, Jens Lehmann, John K. Ramage, Jolie Ringash, et al.

(2024) EUROPEAN JOURNAL OF CANCER. 212.

Add to list

Journal Article
A1
open access

Radiotherapy in cutaneous lymphomas : recommendations from the EORTC cutaneous lymphoma tumour group

Khaled Elsayad, Emmanuella Guenova, Chalid Assaf, Jan P. Nicolay, Franz Trautinger, Rudolf Stadler, Cora Waldstein, Tom Boterberg (UGent) , Paul Meijnders, Youlia Kirova, et al.

(2024) EUROPEAN JOURNAL OF CANCER. 212.

Add to list

Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres : a population-based study in Belgium

Roos Leroy, Geert Silversmit, Jolyce Bourgeois, Cindy De Gendt, Isabelle Savoye, Julie Verbeeck, Nancy Van Damme, Sabine Stordeur, Jean-Luc Canon, Birgit Carly, et al.

(2024) EUROPEAN JOURNAL OF CANCER. 210.

Add to list

Journal Article
A1
open access

METRO-PD1 : phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors

Nicolas André, Marie Cécile Le Deley, Clémence Léguillette, Alicia Probst, Leen Willems (UGent) , Romain Travers, Isabelle Aerts, Cécile Faure-Conter, Gabriel Revond-Riviere, Victoria Min, et al.

(2024) EUROPEAN JOURNAL OF CANCER. 198.

Add to list

Journal Article
A1
open access

European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023

Ketty Peris, Maria Concetta Fargnoli, Roland Kaufmann, Petr Arenberger, Lars Bastholt, Nicole Basset Seguin, Veronique Bataille, Lieve Brochez (UGent) , Veronique del Marmol, Reinhard Dummer, et al.

(2023) EUROPEAN JOURNAL OF CANCER. 192.

Add to list

Journal Article
A1
open access

Defining the role of real-world data in cancer clinical research : the position of the European Organisation for Research and Treatment of Cancer

Robbe Saesen, Mieke Van Hemelrijck, Jan Bogaerts, Christopher M. Booth, Jan J. Cornelissen, Andre Dekker, Elizabeth A. Eisenhauer, Andre Freitas, Alessandro Gronchi, Miguel A. Hernan, et al.

(2023) EUROPEAN JOURNAL OF CANCER. 186. p.52-61

Add to list

Journal Article
A1
open access

Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer : report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal Shore, Eric Small, Matthew Smith, et al.

(2023) EUROPEAN JOURNAL OF CANCER. 185. p.178-215

Add to list

Journal Article
A1
open access

Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumours

Patrick Schoffski, Jean -Pascal Machiels, Sylvie Rottey (UGent) , Behbood Sadrolhefazi, Hanny Musa, Kristell Marzin and Ahmad Awada

(2023) EUROPEAN JOURNAL OF CANCER. 191.

Academic Bibliography

Tumor Treating Fields therapy in platinum-resistant ovarian cancer : results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study

Preliminary safety and pharmacokinetics of the MET-TKI DO-2 in patients with advanced solid tumors harboring MET aberrations : a phase I study

Improving completion rates of patient-reported outcome measures in cancer clinical trials : scoping review investigating the implications for trial designs

Radiotherapy in cutaneous lymphomas : recommendations from the EORTC cutaneous lymphoma tumour group

Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres : a population-based study in Belgium

METRO-PD1 : phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors

European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023

Defining the role of real-world data in cancer clinical research : the position of the European Organisation for Research and Treatment of Cancer

Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer : report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumours

Contents

Support

Contact